Russell Pontinen v. United States Steel Corporati ( 2022 )

In the
United States Court of Appeals
For the Seventh Circuit
____________________
No. 21‐1612
RUSSELL PONTINEN,
Plaintiff‐Appellant,
v.
UNITED STATES STEEL CORPORATION,
Defendant‐Appellee.
____________________
Appeal from the United States District Court for the
Northern District of Indiana, Hammond Division.
No. 18‐cv‐232 — Andrew P. Rodovich, Magistrate Judge.
____________________
ARGUED NOVEMBER 3, 2021 — DECIDED FEBRUARY 11, 2022
____________________
Before KANNE, BRENNAN, and KIRSCH, Circuit Judges.
KANNE, Circuit Judge. Russell Pontinen applied to work as
a Utility Person at United States Steel Corporation’s (“USS”)
Midwest Plant and received a contingent employment offer.
After a diligent investigation, USS discovered that Pontinen
suffered from an uncontrolled seizure disorder and imposed
work restrictions on him. The restrictions conflicted with the
requirements of the position he applied for, so USS rescinded
its employment offer. Because USS has carried its burden to
2 No. 21‐1612
show that Pontinen’s seizure disorder would pose a direct
threat to himself and others at its Midwest Plant, summary
judgment on his ADA claim was proper.
I. BACKGROUND
Russell Pontinen has experienced three or four seizures
during his lifetime. The first occurred when he was eight
years old, and the second when he was twenty‐two. His third
seizure happened in June 2014 and was followed two months
later by what he now calls a “heat‐related illness,” but what
may very well have been a fourth seizure. Before his second
and third seizures, Pontinen says he felt “fuzziness” in his left
eye, a “warning signal” of sorts. The signal gave him some‐
where between thirty seconds and two minutes to prepare.
After the June 2014 seizure, Pontinen began seeing Dr.
George Abu‐Aita, a neurologist. Dr. Abu‐Aita determined
that Pontinen’s seizure disorder was “not well controlled”
and prescribed him Trileptal, but Pontinen experienced neg‐
ative side effects from the drug and failed to take it “faithfully
and daily.” After the possible seizure in August 2014, Dr. Abu‐
Aita switched Pontinen to a medication called Depakote. By
the end of October 2014, Dr. Abu‐Aita thought the seizure dis‐
order was “well controlled with Depakote.” His notes
warned, “Do not miss your medication.”
Each February from 2015 to 2017, Pontinen saw Dr. Abu‐
Aita again for follow‐up appointments. In 2015, Dr. Abu‐Aita
wrote that the seizure disorder “seem[ed] to be well con‐
trolled,” that Pontinen reported missing doses “once in a blue
moon,” and that he told Pontinen he should never do that.
In 2016, Dr. Abu‐Aita reported for the first time that Pon‐
tinen asked “if he can get off the Depakote.” Dr. Abu‐Aita
No. 21‐1612 3
added, “I told him since he had three seizures in his life and
he has a sister with seizures he is at higher risk of having sei‐
zures in the future, I do not recommend being off medica‐
tion.” He acknowledged that Pontinen agreed to stick with
Depakote for another year and reiterated, “Do not miss taking
your medication.”
In 2017, Dr. Abu‐Aita noted that Pontinen “is still asking
me … to stop taking the medication.” Dr. Abu‐Aita told him
that “he is at higher risk of having seizures at any time,” but
Pontinen “still insist[ed].” Finally, Dr. Abu‐Aita relented:
“Since it is his decision to get off the medication I will reduce
the Depakote 1000 mg every night for a month and if no sei‐
zures to 500 mg every night for a month and if no seizure to
stop it.”
A few months later, in May 2017, Pontinen applied to
work as a Utility Person at USS’s Midwest Plant. Those who
hold the Utility Person position “operate[] equipment and
perform[] tasks that support the various production and ser‐
vice units.” They perform “general labor duties that include
the use of torches, shovels and other hand tools,” and control
“mobile equipment, in a heavy industrial environment.” It is
a “safety‐sensitive” and “safety‐critical” position that in‐
volves
safety hazards associated with being around and us‐
ing pneumatic equipment, oxygen lances, power ac‐
tuated tools and torches; … handling, transporting,
processing product and materials; … working with
and around materials that may be hot, heavy or
sharp, and hazardous chemicals; … assisting in in‐
specting and performing maintenance on equip‐
ment; and … working in close proximity to molten
metal.
4 No. 21‐1612
They are at risk of “burn injuries, falls, and being struck by
equipment.” After a brief training period, Utility Persons are
“expected to move into a Utility Technician position which in‐
cludes operati[ng] … overhead and mobile cranes of various
sizes and types, tractors, trucks, dozers, loaders, boom trucks,
and feeders.”
Pontinen received an employment offer contingent upon
passing a pre‐placement fitness‐for‐duty examination. The
exam, conducted by Nurse Practitioner Jennifer Ntovas on
May 15, 2017, revealed that Pontinen had a history of seizures.
Before the exam, Pontinen disclosed on his Health Inventory
Form that he had had four seizures in his life. Then, during
the examination, Ntovas wrote, using the medical shorthand
for “without,” that Pontinen “stopped Depakote [without]
neurologist approval.” After the exam, she signed and dated
a form (“Restrictions Form”) that would later be filled in with
any work restrictions that she thought necessary to impose on
Pontinen.
Next, Ntovas sought information from Pontinen’s treating
neurologist, Dr. Abu‐Aita. Using a Medical Referral form, she
requested from Dr. Abu‐Aita a “diagnosis, plan of care, last
MRI/EEG, date last seen, last documented seizure (and type),
and if compliant [with] medication.” She explained that the
Utility Person position “may involve temperature extremes,
pushing, pulling, [and] extensive ambulation.” Dr. Abu‐Aita
returned the form with a box checked that indicated that his
medical findings “are not expected to affect the safety or
health as it relates to the job.” He also had Pontinen undergo
an EEG, which found “no focal, lateralized, or epileptiform
discharge noted”—a normal result. He did not otherwise re‐
spond to Ntovas’s request for information.
No. 21‐1612 5
Another consideration that USS makes in assessing
whether an applicant is qualified for the Utility Person posi‐
tion is whether they meet the requirements of the U.S. Depart‐
ment of Transportation’s (“DOT”) Federal Motor Carrier
Safety Administration Medical Handbook. 49 C.F.R. § 391.41(2021). The handbook sets certain physical qualifications for
drivers of commercial motor vehicles. One such qualification
is that the driver “[h]as no established medical history or clin‐
ical diagnosis of epilepsy or any other condition which is
likely to cause loss of consciousness or any loss of ability to
control a commercial motor vehicle.” Id. § 391.41(b)(8).
Generally, the regulations require an unmedicated driver
to be seizure‐free for ten years, but a driver with a seizure‐
disorder diagnosis can apply for a reduction of the require‐
ment to eight seizure‐free years, on or off medication. See Fed.
Motor Carrier Safety Admin., Federal Seizure Exemption Appli‐
cation, FMCSA, https://www.fmcsa.dot.gov/medical/driver‐
medical‐requirements/new‐seizure‐applicant‐doc‐email‐ver‐
sion (last updated April 19, 2021). If the driver is taking med‐
ication, the type, dosage, and frequency must be stable for
two years. Id.
Based upon the DOT regulations, the Health Inventory
Form, the physical examination, Dr. Abu‐Aita’s response to
the Medical Referral form, and Dr. Abu‐Aita’s treatment
notes, Ntovas and USS Medical Director, Dr. Philippa Nor‐
man, determined appropriate work restrictions for Pontinen.
They determined that he could work, but only if he avoided
“jobs higher than five feet, … Extensive Stairs/Ladder/Free
Climbing, … Exposure to Hazardous Machinery,” and oper‐
ating “cranes or mobile equipment.” Pontinen was also
6 No. 21‐1612
required to seek “[a]pproval through Medical prior to job
change.”
The restrictions were sent to the Human Resources (“HR”)
Department, which concluded that these restrictions could
not be accommodated. On July 17, 2017, USS notified Pon‐
tinen that “based on the results of [his] pre‐placement fitness
for duty examination,” his offer of employment was re‐
scinded.
Pontinen sued USS in the Northern District of Indiana for
disability discrimination under the Americans with Disabili‐
ties Act (“ADA”). He argued that USS illegally discriminated
against him on the basis of a real or perceived disability when
it rescinded his employment offer. The parties consented to
proceed before a magistrate judge, including trial, final judg‐
ment, and all post‐judgment proceedings. In September 2020,
USS filed a motion for summary judgment, which the district
court granted because Pontinen’s “uncontrolled epileptic con‐
dition would have posed a direct threat to the health and
safety of himself and others while working at USS.” Pontinen
now appeals.
II. ANALYSIS
We review de novo a district court’s grant of summary
judgment. Darnell v. Thermafiber, Inc., 417 F.3d 657, 659 (7th
Cir. 2005). Summary judgment is appropriate if, construing
all facts and inferences in the light most favorable to Pontinen,
there is no genuine issue as to any material fact and USS is
entitled to judgment as a matter of law. See id.Among other things, the ADA prohibits certain employers
from “discriminat[ing] against a qualified individual on the
basis of disability in regard to … hiring.” 42 U.S.C. § 12112(a).
No. 21‐1612 7
A qualified individual is “an individual who, with or without
reasonable accommodation, can perform the essential func‐
tions” of the job. Id. § 12111(8). One form of impermissible dis‐
crimination is “using qualification standards, employment
tests or other selection criteria that screen out or tend to screen
out an individual with a disability or a class of individuals
with disabilities unless the standard … is shown to be job‐re‐
lated … and is consistent with business necessity.” Id.
§ 12112(b)(6). Accordingly, a requirement that a potential em‐
ployee “not pose a direct threat to the health or safety of oth‐
ers in the workplace,” is permissible, even if it tends to dis‐
criminate. Id. § 12113(b). This rule also extends to a require‐
ment that an individual not pose a threat to his own health
and safety in the workplace. Chevron U.S.A. Inc. v. Echazabal,
536 U.S. 73, 76 (2002) (approving of EEOC regulation expand‐
ing direct‐threat defense).
While it is the plaintiff‐employee’s burden to show that he
is a “qualified individual,” which means he can perform the
“essential functions” or “duties” of the job with or without
reasonable accommodation, 42 U.S.C. § 12111(8); 29 C.F.R.
§ 1630.2(n)(1), it is the defendant‐employer’s burden to show
that qualification standards that “tend to screen out … indi‐
vidual[s] with a disability” escape liability because those
qualification standards are necessary to prevent “a direct
threat to the health or safety of other individuals in the work‐
place.” 42 U.S.C. § 12113(a)–(b); Branham v. Snow, 392 F.3d
896, 907 (7th Cir. 2004). Thus, the difference between “quali‐
fied individual” and “qualification standards” is “crucial” be‐
cause it impacts which party bears the burden of proof. See
Bates v. United Parcel Serv., Inc., 511 F.3d 974, 990 (9th Cir.
2007) (en banc).
8 No. 21‐1612
So, what is a direct threat? That term “means a significant
risk of substantial harm … that cannot be eliminated or re‐
duced by reasonable accommodation.” 29 C.F.R. § 1630.2(r)
(2012); see also Branham, 392 F.3d at 905–06. Any determination
that someone poses a direct threat must rely on an “individu‐
alized assessment of the individual’s present ability to safely
perform the essential functions of the job.” 29 C.F.R.
§ 1630.2(r). In turn, “a reasonable medical judgment that re‐
lies on the most current medical knowledge and/or on the best
available objective evidence” must inform the assessment. Id.The assessment must consider: “(1) [t]he duration of the risk;
(2) [t]he nature and severity of the potential harm; (3) [t]he
likelihood that the potential harm will occur; and (4) [t]he im‐
minence of the potential harm.” Id.; see also Stragapede v. City
of Evanston, 865 F.3d 861, 866 (7th Cir. 2017) (citing Emerson v.
N. States Power Co., 256 F.3d 506, 514 (7th Cir. 2001)).
A. Adequate Medical Evidence
Before engaging the substance of the direct‐threat analy‐
sis, we seek to understand whether the employer’s decision
was based on appropriate evidence and a truly individualized
assessment. See Darnell, 417 F.3d at 660. Here, the ultimate de‐
cision by USS was based on the restrictions determined by
Ntovas and Dr. Norman. Therefore, their analysis is what
must be a “reasonable medical judgment” that relies on ap‐
propriate evidence.
Ntovas and Dr. Norman considered the DOT regulations;
the Health Inventory Form; the physical examination; Dr.
Abu‐Aita’s response to the Medical Referral form, including
the clean EEG; and Dr. Abu‐Aita’s treatment notes. These
sources all either represent “current medical knowledge” or
are the “best available objective evidence.” To the extent that
No. 21‐1612 9
Ntovas and Dr. Norman gave more weight to some of the ev‐
idence, that was within their “reasonable medical judgment.”
There is no question, however, that their judgment was
premised on the consideration of adequate evidence, as con‐
templated by the ADA and supporting regulations. See, e.g.,
Darnell, 417 F.3d at 660 (noting that even “testimonial evi‐
dence can provide sufficient support for a direct threat find‐
ing”); Bekker v. Humana Health Plan, Inc., 229 F.3d 662, 668 (7th
Cir. 2000) (approving of district court analysis finding that
“employee and patient reports of her smelling of alcohol con‐
stituted sufficiently objective evidence”).
B. Individualized Assessment
Pontinen argues that the assessment USS conducted was
not sufficiently individual. He contends that he was “categor‐
ically disqualified based on preconceived notions of ‘sei‐
zures.’” Appellant’s Br. at 27. But that is not true.
The restrictions were based primarily on the fact that Pon‐
tinen suffers from an uncontrolled seizure disorder. This was
evident from Pontinen’s own statements that he stopped tak‐
ing Depakote, Ntovas’s notes from the fitness‐for‐duty exam,
and Dr. Abu‐Aita’s progress notes, among other things. It is
also undisputed that when Pontinen has seizures, he tends to
lose consciousness. Therefore, USS’s imposition of restrictions
was based on information pertinent to Pontinen’s personal ex‐
perience with his seizure disorder. That is sufficiently individ‐
ual.
Pontinen also argues that reliance on the DOT regulations
constituted impermissible categorical discrimination. He
points to Ntovas’s statement in her deposition that she would
have imposed the same restrictions even if Pontinen had
10 No. 21‐1612
never stopped taking Depakote. That statement addresses an
interesting hypothetical that would present a different ques‐
tion to our court. That question would be: If USS’s decision
were based exclusively on the DOT regulations, would that
constitute an individualized assessment? However, in the
case before us, the restrictions were based on much more than
the DOT regulations. And it is beyond dispute that the re‐
maining evidence is highly individualized.
C. Pontinen’s Seizure Disorder is Uncontrolled
Next, we agree with the district court that whether Pon‐
tinen’s seizure disorder was controlled is a material fact about
which there is no genuine dispute. Pontinen argues that USS
“and its medical personnel conflated the fact that [he] was not
actively medicated with his condition being ‘uncontrolled’
and that he had disregarded his neurologist’s treatment
plan.” Appellant’s Br. at 20.
He claims that a few pieces of evidence support his con‐
tention. First, although Ntovas wrote on his examination form
that he stopped Depakote without Dr. Abu‐Aita’s approval,
Pontinen claims her deposition transcript refutes the assertion
because Ntovas could not recall what specifically Pontinen
told her. And in his own deposition, he claims she mischarac‐
terized his answers in arriving at that conclusion. Second, his
EEG results were normal. Third, he was on medication and
seizure‐free for almost three years. Fourth, he asserts that he
only came off of Depakote with Dr. Abu‐Aita’s approval, and
that the neurologist’s progress notes show that. And fifth, the
Medical Referral form that Dr. Abu‐Aita returned to Ntovas
cleared him to work with no restrictions.
No. 21‐1612 11
None of these pieces of evidence create a genuine dispute.
Dr. Abu‐Aita’s progress notes are clear: Pontinen’s seizure
disorder was “not well controlled” when he first started see‐
ing him but was “well controlled with Depakote.” He repeat‐
edly told Pontinen to never miss a dose because he is at a high
risk for having a seizure. Pontinen repeatedly asked to stop
taking Depakote but agreed to keep taking it at Dr. Abu‐Aita’s
request.
But, in February 2017, he stopped agreeing and “in‐
sist[ed]” on coming off, despite the high risk. Only then,
“[s]ince it is [Pontinen’s] decision to get off the medication,”
did the neurologist ensure it was done as safely as possible by
showing him how to wean himself off of it. Dr. Abu‐Aita un‐
equivocally did not approve of the decision.
The dispute about what was said to Ntovas at the physical
examination does nothing to refute what is clear in the notes.
Next, the fact that he had no seizures while taking medication
actually works against Pontinen, showing the benefits of con‐
trolling his disorder with medication. The same can be said
for the clean EEG, taken shortly after he came off of Depakote.
Finally, the fact that Dr. Abu‐Aita cleared him to work at USS
with no restrictions likewise speaks to the good condition he
was in shortly after coming off of Depakote, but does not con‐
tradict in any way that his seizure disorder had become un‐
controlled and that the risk of a seizure had markedly in‐
creased.
The evidence shows that Pontinen stopped listening to his
neurologist and doing the one thing that brought his disorder
under control. Therefore, we agree that the undisputed evi‐
dence shows that his disorder was uncontrolled at the time he
applied to work as a Utility Person at USS. See Darnell, 417
12 No. 21‐1612
F.3d at 659–61 (finding that applicant who was “disinter‐
est[ed] in regulating his condition” had uncontrolled diabe‐
tes). Now that his disorder is not under control, Pontinen has
returned to a state of high risk for a seizure.
D. Direct Threat Analysis
“[I]n order to prevail on its summary judgment motion as‐
serting that [Pontinen] posed a direct threat to himself and
others, [USS] must show that the evidence on the question of
direct threat is so one‐sided no reasonable jury could find for
[Pontinen].” Branham, 392 F.3d at 907 (citing Anderson v. Lib‐
erty Lobby, 477 U.S. 242, 251–52 (1986)).
1. Duration of the Risk
The first factor that the ADA requires us to assess is the
duration of the risk. The parties dispute whether the duration
of the risk is the length of one seizure or indefinite. The district
court relied on E.E.O.C. v. Rexnord Industries, LLC for the
proposition that, “[g]enerally speaking, if the risk is not con‐
trolled or controllable, the duration is indefinite and thus
would weigh more heavily in favor of a finding of direct
threat.” 966 F. Supp. 2d 829, 837 (E.D. Wis. 2013) (collecting
Seventh Circuit cases, among others). We recognize that there
is contrary nonbinding authority, see, e.g., E.E.O.C. v. Kinney
Shoe Corp., 917 F. Supp. 419, 429 (W.D. Va. 1996) (finding that
duration of risk of seizure was fleeting), but we agree with the
Rexnord proposition, at least as applied here. Dr. Abu‐Aita
warned Pontinen that going off of his medication would put
him at an elevated risk of having a seizure, yet he insisted on
discontinuing his medication. We find that the duration of the
risk is indefinite. This weighs in favor of a direct‐threat find‐
ing.
No. 21‐1612 13
2. Nature and Severity of Potential Harm
The next area of assessment is the nature and severity of
potential harm. Pontinen argues that the nature and severity
of the potential harm are low because he sometimes gets a
“warning signal” anywhere from thirty seconds to two
minutes before the seizure’s onset. He argues that this gives
him enough time to remove himself from any dangerous sit‐
uation, retreat to a safe place, and prepare for the seizure. He
told this to Dr. Abu‐Aita, who wrote it in his notes. However,
he only got a warning signal before two of his three or four
seizures, so it is not guaranteed that it would happen again.
And if warned, there is no guarantee how much warning he
would get or that he would be able to get to safety. Consider‐
ing Pontinen’s seizures cause him to lose consciousness, the
consequences in the Midwest Plant could be disastrous.
We already recited at length the requirements of the
“safety‐critical” Utility Person position. It involves working
with and around torches, shovels, power actuated tools, mo‐
bile equipment, pneumatic equipment, oxygen lances, mate‐
rials that may be hot, heavy, or sharp, hazardous chemicals,
and molten metal, and will involve, eventually, cranes, trac‐
tors, trucks, dozers, loaders, boom trucks, and feeders.
Given the unreliability of his warning signal and the po‐
tentially catastrophic consequences of losing consciousness in
this dangerous setting, the nature and severity of the risk nec‐
essarily weigh in favor of a direct‐threat finding.
3. Likelihood that Harm Will Occur
We have “recognized that where the plaintiff’s medical
condition is uncontrolled, of an unlimited duration, and ca‐
pable of causing serious harm, injury may be considered
14 No. 21‐1612
likely to occur.” Darnell, 417 F.3d at 662 (citing Bekker, 229 F.3d
at 668). The best available objective medical evidence here
demonstrates that all three of these characteristics are true
with respect to Pontinen’s seizure disorder. Therefore, we
conclude that harm is likely to occur, and this factor also fa‐
vors a direct‐threat finding.
4. Imminence of Harm
Finally, with respect to imminence, the undisputed evi‐
dence is more mixed. Pontinen’s medical history shows only
four seizures spread over many years, so it is true that they
are fairly rare. However, just before and after he began con‐
trolling his seizure disorder with Depakote, there were two
incidents in as many months. And now that he has stopped
taking the medication, he is at a higher risk of having a sei‐
zure. It is possible that he could have a seizure at any moment,
but most of his seizures have been separated by long, une‐
ventful periods. This factor weighs in favor of USS, but not as
heavily as the others.
5. Weighing the Factors
Because all of the factors weigh in favor of finding that
there is a direct threat, we are compelled to reach that conclu‐
sion. While Pontinen can point to a few pieces of evidence that
support the idea that he has been doing well, he cannot point
to evidence that creates a genuine dispute of material fact
with regard to whether USS’s decision to rescind his employ‐
ment offer because he constituted a threat to himself and oth‐
ers was proper. The evidence shows that USS’s determination
relied on appropriate evidence, was made after an individu‐
alized assessment, and revealed an uncontrolled seizure dis‐
order that would create an intolerable risk at its Midwest
No. 21‐1612 15
Plant. In other words, “the evidence on the question of direct
threat is so one‐sided [that] no reasonable jury could find for
[Pontinen].” Branham, 392 F.3d at 907. Therefore, it was not a
violation of the ADA for USS to rescind, on that basis, the job
offer it extended to Pontinen.
* * *
Although USS also raised in the district court the argu‐
ment that Pontinen cannot make out a prima facie case of dis‐
ability discrimination because he cannot show that his seizure
disorder was the “but for” cause of the decision to rescind his
offer, the district court found that argument unnecessary to
address, instead finding the direct‐threat analysis dispositive.
USS again raises this argument on appeal, but considering the
outcome of our direct‐threat analysis, we, too, have no need
to address this argument.
III. CONCLUSION
Because USS has shown through undisputed evidence
that, if hired for the Utility Person position, Pontinen’s seizure
disorder would pose a direct threat to himself and others at
the Midwest Plant, summary judgment was proper. We
AFFIRM.